SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-211895
Filing Date
2011-08-05
Accepted
2011-08-05 13:15:34
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 342115
2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF PEO dex311.htm EX-31.1 6076
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF PFO dex312.htm EX-31.2 6074
4 CERTIFICATION OF PEO AND PFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 6420
  Complete submission text file 0001193125-11-211895.txt   1891413

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgen-20110630.xml EX-101.INS 238021
6 XBRL TAXONOMY EXTENSION SCHEMA rgen-20110630.xsd EX-101.SCH 14958
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20110630_cal.xml EX-101.CAL 35603
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20110630_def.xml EX-101.DEF 93925
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20110630_lab.xml EX-101.LAB 89077
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20110630_pre.xml EX-101.PRE 102832
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 111013418
SIC: 2836 Biological Products, (No Diagnostic Substances)